Dursun, A. B. Et Al. 2016. Omalizumab in adult patients with refractory chronic idiopathic urticaria: real-life outcomes. Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology , (Vienna, Austria), 187.

Dursun, A. B., Karakis, P. G., & Ayhan, V., (2016). Omalizumab in adult patients with refractory chronic idiopathic urticaria: real-life outcomes . Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology (pp.187). Vienna, Austria

Dursun, A., Pasaoglu G. Karakis, And V Ayhan. "Omalizumab in adult patients with refractory chronic idiopathic urticaria: real-life outcomes," Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology, Vienna, Austria, 2016

Dursun, A. B. Et Al. "Omalizumab in adult patients with refractory chronic idiopathic urticaria: real-life outcomes." Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology , Vienna, Austria, pp.187, 2016

Dursun, A. B. Karakis, P. G. And Ayhan, V. (2016) . "Omalizumab in adult patients with refractory chronic idiopathic urticaria: real-life outcomes." Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology , Vienna, Austria, p.187.

@conferencepaper{conferencepaper, author={A. B. Dursun Et Al. }, title={Omalizumab in adult patients with refractory chronic idiopathic urticaria: real-life outcomes}, congress name={Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology}, city={Vienna}, country={Austria}, year={2016}, pages={187} }